
Janet L. Coppins
Examiner (ID: 9929, Phone: (571)272-0680 , Office: P/1672 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1621, 1672, 1628, 1625, 1626 |
| Total Applications | 1605 |
| Issued Applications | 1046 |
| Pending Applications | 231 |
| Abandoned Applications | 369 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18737876
[patent_doc_number] => 20230346776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => VETERINARY COMPOSITION FOR DAIRY RUMINANTS FOR TREATMENT OF MILK FEVER
[patent_app_type] => utility
[patent_app_number] => 17/793328
[patent_app_country] => US
[patent_app_date] => 2021-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3587
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17793328
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/793328 | VETERINARY COMPOSITION FOR DAIRY RUMINANTS FOR TREATMENT OF MILK FEVER | Jan 25, 2021 | Pending |
Array
(
[id] => 19825260
[patent_doc_number] => 12246014
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-11
[patent_title] => Azetidine derivatives
[patent_app_type] => utility
[patent_app_number] => 17/148785
[patent_app_country] => US
[patent_app_date] => 2021-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13899
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17148785
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/148785 | Azetidine derivatives | Jan 13, 2021 | Issued |
Array
(
[id] => 18150526
[patent_doc_number] => 20230024384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => COMPOSITION COMPRISING LISURIDE COMPOUND FOR TREATING FRAGILE X SYNDROME OR RELATED DEVELOPMENTAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/790891
[patent_app_country] => US
[patent_app_date] => 2021-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5660
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17790891
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/790891 | COMPOSITION COMPRISING LISURIDE COMPOUND FOR TREATING FRAGILE X SYNDROME OR RELATED DEVELOPMENTAL DISORDERS | Jan 7, 2021 | Pending |
Array
(
[id] => 18166621
[patent_doc_number] => 20230033224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => CICLESONIDE FOR AMELIORATING QUALITY OF LIFE (QOL) IN EQUINES
[patent_app_type] => utility
[patent_app_number] => 17/758427
[patent_app_country] => US
[patent_app_date] => 2021-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4357
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17758427
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/758427 | CICLESONIDE FOR AMELIORATING QUALITY OF LIFE (QOL) IN EQUINES | Jan 5, 2021 | Pending |
Array
(
[id] => 19666093
[patent_doc_number] => 12178813
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-31
[patent_title] => CGRP receptor antagonists
[patent_app_type] => utility
[patent_app_number] => 17/139299
[patent_app_country] => US
[patent_app_date] => 2020-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12382
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17139299
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/139299 | CGRP receptor antagonists | Dec 30, 2020 | Issued |
Array
(
[id] => 18946998
[patent_doc_number] => 11890270
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-06
[patent_title] => Polymorphic forms of ST-246 and methods of preparation
[patent_app_type] => utility
[patent_app_number] => 17/136674
[patent_app_country] => US
[patent_app_date] => 2020-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 16966
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17136674
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/136674 | Polymorphic forms of ST-246 and methods of preparation | Dec 28, 2020 | Issued |
Array
(
[id] => 19097735
[patent_doc_number] => 20240116963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => DENDRIMERS HAVING THIOPHOSPHORAMIDATE PATTERNS AND DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/788114
[patent_app_country] => US
[patent_app_date] => 2020-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25680
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17788114
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/788114 | DENDRIMERS HAVING THIOPHOSPHORAMIDATE PATTERNS AND DERIVATIVES | Dec 21, 2020 | Pending |
Array
(
[id] => 18182474
[patent_doc_number] => 20230043204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => DIHYDROERGOTAMINE MESYLATE FORMULATIONS AND PRE-FILLED INJECTORS FOR THERAPEUTIC DELIVERY OF THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/757924
[patent_app_country] => US
[patent_app_date] => 2020-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20565
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -112
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17757924
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/757924 | DIHYDROERGOTAMINE MESYLATE FORMULATIONS AND PRE-FILLED INJECTORS FOR THERAPEUTIC DELIVERY OF THE SAME | Dec 20, 2020 | Pending |
Array
(
[id] => 18182474
[patent_doc_number] => 20230043204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => DIHYDROERGOTAMINE MESYLATE FORMULATIONS AND PRE-FILLED INJECTORS FOR THERAPEUTIC DELIVERY OF THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/757924
[patent_app_country] => US
[patent_app_date] => 2020-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20565
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -112
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17757924
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/757924 | DIHYDROERGOTAMINE MESYLATE FORMULATIONS AND PRE-FILLED INJECTORS FOR THERAPEUTIC DELIVERY OF THE SAME | Dec 20, 2020 | Pending |
Array
(
[id] => 16913891
[patent_doc_number] => 20210186983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => ORALLY ADMINISTERED COMBINATIONS OF AMOXICILLIN AND AVIBACTAM DERIVATIVES FOR TREATING MYCOBACTERIAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/123858
[patent_app_country] => US
[patent_app_date] => 2020-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22067
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -57
[patent_words_short_claim] => 275
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17123858
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/123858 | ORALLY ADMINISTERED COMBINATIONS OF AMOXICILLIN AND AVIBACTAM DERIVATIVES FOR TREATING MYCOBACTERIAL INFECTIONS | Dec 15, 2020 | Abandoned |
Array
(
[id] => 17168671
[patent_doc_number] => 20210322341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => LOW DOSAGE SEROTONIN 5-HT2A RECEPTOR AGONIST TO SUPPRESS INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 17/108153
[patent_app_country] => US
[patent_app_date] => 2020-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9238
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17108153
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/108153 | LOW DOSAGE SEROTONIN 5-HT2A RECEPTOR AGONIST TO SUPPRESS INFLAMMATION | Nov 30, 2020 | Abandoned |
Array
(
[id] => 16898863
[patent_doc_number] => 20210177779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => COMBINATIONS OF OPIOIDS AND N-ACYLETHANOLAMINES
[patent_app_type] => utility
[patent_app_number] => 17/105687
[patent_app_country] => US
[patent_app_date] => 2020-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11393
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17105687
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/105687 | COMBINATIONS OF OPIOIDS AND N-ACYLETHANOLAMINES | Nov 26, 2020 | Pending |
Array
(
[id] => 16686696
[patent_doc_number] => 20210069171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => NUTRITIONAL SUPPLEMENT FOR IMPROVING SEXUAL HEALTH IN MEN AND WOMEN
[patent_app_type] => utility
[patent_app_number] => 16/953110
[patent_app_country] => US
[patent_app_date] => 2020-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1229
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16953110
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/953110 | NUTRITIONAL SUPPLEMENT FOR IMPROVING SEXUAL HEALTH IN MEN AND WOMEN | Nov 18, 2020 | Abandoned |
Array
(
[id] => 16805954
[patent_doc_number] => 20210128507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => FORMULATION FOR USE IN A METHOD OF TREATMENT OF PAIN
[patent_app_type] => utility
[patent_app_number] => 17/098923
[patent_app_country] => US
[patent_app_date] => 2020-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6550
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098923
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/098923 | FORMULATION FOR USE IN A METHOD OF TREATMENT OF PAIN | Nov 15, 2020 | Abandoned |
Array
(
[id] => 16655978
[patent_doc_number] => 20210052614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => BORON-CONTAINING SMALL MOLECULES FOR INHIBITING ACTIVITY OF A RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASE
[patent_app_type] => utility
[patent_app_number] => 17/087962
[patent_app_country] => US
[patent_app_date] => 2020-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10020
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17087962
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/087962 | BORON-CONTAINING SMALL MOLECULES FOR INHIBITING ACTIVITY OF A RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASE | Nov 2, 2020 | Abandoned |
Array
(
[id] => 16791620
[patent_doc_number] => 20210121437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => THERAPEUTIC AGENTS CONTAINING CANNABIS FLAVONOID DERIVATIVES TARGETING KINASES, SIRTUINS AND ONCOGENIC AGENTS FOR THE TREATMENT OF MULTIPLE MYELOMA, LYMPHOMA, AND LEUKEMIA
[patent_app_type] => utility
[patent_app_number] => 17/083716
[patent_app_country] => US
[patent_app_date] => 2020-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6049
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17083716
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/083716 | THERAPEUTIC AGENTS CONTAINING CANNABIS FLAVONOID DERIVATIVES TARGETING KINASES, SIRTUINS AND ONCOGENIC AGENTS FOR THE TREATMENT OF MULTIPLE MYELOMA, LYMPHOMA, AND LEUKEMIA | Oct 28, 2020 | Abandoned |
Array
(
[id] => 16655880
[patent_doc_number] => 20210052516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => METHOD FOR INCREASING AKKERMANSIA IN INTESTINAL BACTERIAL FLORA BY INGESTING ASTAXANTHIN
[patent_app_type] => utility
[patent_app_number] => 17/080118
[patent_app_country] => US
[patent_app_date] => 2020-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3742
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17080118
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/080118 | METHOD FOR INCREASING AKKERMANSIA IN INTESTINAL BACTERIAL FLORA BY INGESTING ASTAXANTHIN | Oct 25, 2020 | Abandoned |
Array
(
[id] => 16961462
[patent_doc_number] => 20210212961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => CANNABINOID-CONTAINING COMPLEX MIXTURES FOR THE TREATMENT OF MAST CELL-ASSOCIATED OR BASOPHIL-MEDIATED INFLAMMATORY DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/065400
[patent_app_country] => US
[patent_app_date] => 2020-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15214
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17065400
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/065400 | CANNABINOID-CONTAINING COMPLEX MIXTURES FOR THE TREATMENT OF MAST CELL-ASSOCIATED OR BASOPHIL-MEDIATED INFLAMMATORY DISORDERS | Oct 6, 2020 | Abandoned |
Array
(
[id] => 16748757
[patent_doc_number] => 20210100766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => METHODS OF SUSTAINING DIETARY KETOSIS AND ITS EFFECTS ON LIPID PROFILE
[patent_app_type] => utility
[patent_app_number] => 17/063183
[patent_app_country] => US
[patent_app_date] => 2020-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7437
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17063183
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/063183 | METHODS OF SUSTAINING DIETARY KETOSIS AND ITS EFFECTS ON LIPID PROFILE | Oct 4, 2020 | Abandoned |
Array
(
[id] => 16596464
[patent_doc_number] => 20210022995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => INTRANASAL DELIVERY OF DIHYDROERGOTAMINE BY PRECISION OLFACTORY DEVICE
[patent_app_type] => utility
[patent_app_number] => 17/062364
[patent_app_country] => US
[patent_app_date] => 2020-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13551
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17062364
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/062364 | Intranasal delivery of dihydroergotamine by precision olfactory device | Oct 1, 2020 | Issued |